KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Nov (NOV) EBITDA (2016 - 2025)

Historic EBITDA for Nov (NOV) over the last 17 years, with Q4 2025 value amounting to $92.0 million.

  • Nov's EBITDA fell 5555.56% to $92.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $494.0 million, marking a year-over-year decrease of 4360.73%. This contributed to the annual value of $494.0 million for FY2025, which is 4360.73% down from last year.
  • As of Q4 2025, Nov's EBITDA stood at $92.0 million, which was down 5555.56% from $107.0 million recorded in Q3 2025.
  • In the past 5 years, Nov's EBITDA registered a high of $313.0 million during Q2 2024, and its lowest value of -$88.0 million during Q1 2021.
  • Its 5-year average for EBITDA is $107.6 million, with a median of $134.5 million in 2023.
  • In the last 5 years, Nov's EBITDA soared by 118000.0% in 2022 and then crashed by 5555.56% in 2025.
  • Quarter analysis of 5 years shows Nov's EBITDA stood at -$15.0 million in 2021, then surged by 1180.0% to $162.0 million in 2022, then decreased by 0.62% to $161.0 million in 2023, then increased by 28.57% to $207.0 million in 2024, then tumbled by 55.56% to $92.0 million in 2025.
  • Its EBITDA stands at $92.0 million for Q4 2025, versus $107.0 million for Q3 2025 and $143.0 million for Q2 2025.